Search results
Results from the WOW.Com Content Network
Pseudodementia (otherwise known as depression-related cognitive dysfunction or depressive cognitive disorder) is a condition that leads to cognitive and functional impairment imitating dementia that is secondary to psychiatric disorders, especially depression.
Dementia may occur when neurodegenerative and cerebrovascular pathologies are mixed, as in susceptible elderly people (75 years and older). [2] [5] Cognitive decline can be traced back to occurrence of successive strokes. [4] ICD-11 lists vascular dementia as dementia due to cerebrovascular disease. [1]
AFib, the most common heart rhythm disorder, is linked to a 39% increased risk of cognitive impairment, while coronary heart disease increases the risk of dementia by 27%, with up to 50% of heart ...
Other diseases and conditions that cause NCDs include vascular dementia, frontotemporal degeneration, Lewy body disease, prion disease, normal pressure hydrocephalus, and dementia/neurocognitive issues due to HIV infection (AIDS). [20] They may also include dementia due to substance abuse or exposure to toxins.
If a person is 65 years old and diagnosed with dementia, that means the disease first started in their brains between the ages of 35 to 45.” ... for a heart attack or stroke an older adult ...
If you are one of the millions of Americans with heart disease, you have a higher risk for future dementia, according to the American Heart Association. Common heart conditions raise the risk of ...
While there are different forms of dementia, Vascular dementia as it would sound is associated with vascular cautions. [14] This form of dementia is not a slow deterioration but rather a sudden and unexpected change due to heart attack or stroke [15] significantly reducing blood to the brain. [14]
A clinical trial testing sertraline (Zoloft) for depression of Alzheimer disease, launched by the NIMH in 2004, was due to be completed in the summer of 2009. [9] [needs update] Sertraline, as per the latest studies has been found to be ineffective in improving cognitive outcomes in patients with Alzheimer's disease. [10]